跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 2,409 条关于
“EP2/EP4/DP1”
全部
2,409
临床试验
1,679
药物
590
机构
16
资讯
124
去年
Owkin Initiates Phase I Trial of AI-Optimized Triple Inhibitor OKN4395 for Solid Tumors
去年
Owkin Launches ATLANTIS: AI-Powered Patient Data Mining Initiative Across 20 Global Healthcare Centers
去年
Nxera Pharma Advances Novel EP4 Antagonist HTL0039732 to Phase 2a Trial for Advanced Solid Tumors
2个月前
Tissue-Resident Macrophages Emerge as Master Regulators of Aging Through EP2-Driven Neutrophil Clearance
11个月前
ONO-4578 EP4 Antagonist Combination Shows Significant PFS Improvement in Advanced Gastric Cancer
6个月前
Kainova Therapeutics Reports Positive Phase I Results for Oral EP4 Receptor Antagonist DT-9081 in Advanced Solid Tumors
2年前
Nxera and Cancer Research UK Presenting Phase 1/2a Trial of EP4 Antagonist HTL0039732 at ESMO 2024
8个月前
Korean Anti-Cancer Resistance Drug OCT-598 Begins Phase 1 Clinical Trials Through Public-Private Partnership
去年
Domain Therapeutics to Showcase Novel GPCR-Targeting Oncology Programs at AACR 2025
去年
Ono Pharma to Present Positive Phase 2 Data for Tirabrutinib in PCNSL and ONO-4578 in Rectal Cancer at ASCO 2025
第 1 页,共 13 页
上一页
下一页